Cite
HARVARD Citation
Hillmen, P. et al. (2015). Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial. Lancet. 385 (9980), pp. 1873-1883. [Online].